Neuroblastoma
📧 Sign up to get email alerts when something new happens for Neuroblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-08-08Clinical Trial Update: Iodobenzylguanidine Meta-I131 and Topotecan in Young Patients With Refractory or Relapsed Metastatic Neuroblastoma [Phase 2]
This is a Phase 2 clinical trial update evaluating a combination of metaiodobenzylguanidine (MIBG) labeled with iodine-131 and topotecan in …
-
CLINICAL_TRIALS trial_result · 2016-08-03Clinical Trial Update: T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies [Phase 1]
Phase 1 study of T cell receptor-transduced T cells targeting NY-ESO-1 in patients with NY-ESO-1-expressing malignancies to assess safety an…
-
CLINICAL_TRIALS trial_result · 2016-07-28Clinical Trial Update: Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma [NA]
This document reports a completed clinical trial of molecular guided therapy for refractory or recurrent neuroblastoma, with results posted …
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer
This clinical trial update reports on gene mutation analyses in samples from young patients with Pleuropulmonary Blastoma Syndrome at risk f…
-
CLINICAL_TRIALS trial_result · 2016-06-24Clinical Trial Update: Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma [Phase 1]
A Phase 1 trial evaluating autologous transplant followed by allogeneic transplant for high-risk Neuroblastoma was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-06-21Clinical Trial Update: Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors [Phase 1]
This Phase 1 trial update assesses the safety and feasibility of radiolabeled octreotide in pediatric patients with advanced or refractory s…
-
CLINICAL_TRIALS trial_result · 2016-06-20Clinical Trial Update: Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide [Phase 1]
Phase 1 safety study of DFMO alone and in combination with etoposide in refractory or relapsed neuroblastoma has completed, with results pos…
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: Anti-angiogenetic Therapy With Radiotherapy for Pediatric Neuroblastoma [Phase 2]
Phase 2 clinical trial update evaluating anti-angiogenic therapy combined with radiotherapy for pediatric neuroblastoma.
-
CLINICAL_TRIALS trial_result · 2016-05-24Clinical Trial Update: Response-based Treatment of High-risk Neuroblastoma [Phase 2]
A Phase 2 clinical trial from Samsung Medical Center evaluating response-based treatment for newly diagnosed high-risk neuroblastoma; curren…
-
CLINICAL_TRIALS trial_result · 2016-05-19Clinical Trial Update: Studying Biomarkers in Samples From Patients With High-Risk Neuroblastoma
An update on a completed clinical trial studying biomarkers in samples from patients with high-risk neuroblastoma.
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: Biomarkers in Young Patients With Neuroblastoma
This ClinicalTrials.gov entry reports that a study on biomarkers in young patients with neuroblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: Studying Chromosomes in Samples From Younger Patients With Neuroblastoma
The update reports a completed trial investigating chromosomal analyses in samples from younger neuroblastoma patients. It is sponsored by t…
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: Study of DNA in Blood Samples From Patients With Neuroblastoma
A completed clinical trial investigating DNA in blood samples from patients with neuroblastoma, sponsored by the Children's Oncology Group.
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: Studying Gene Expression in Samples From Younger Patients With Neuroblastoma
A completed clinical trial update studying gene expression in samples from younger patients with neuroblastoma.
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: Gene Expression in Predicting Outcome in Samples From Patients With High-Risk Neuroblastoma
This completed trial from the Children's Oncology Group investigates whether gene expression patterns in tumor samples can predict outcomes …
-
CLINICAL_TRIALS trial_result · 2016-03-02Clinical Trial Update: A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB [Phase 1, Phase 2]
Phase I dose-finding and safety study of LDE225 (sonidegib) in children with recurrent or refractory medulloblastoma, with a Phase II portio…
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006) [Phase 1]
Phase 1 trial of robatumumab (SCH 717454, MK-7454) in combination with different regimens in pediatric participants with advanced solid tumo…
-
CLINICAL_TRIALS trial_result · 2016-02-09Clinical Trial Update: MLN8237 to Treat Children With Relapsed/Refractory Solid Tumors [Phase 1]
Phase 1 trial update showing completion of MLN8237 (alisertib) in children with relapsed/refractory solid tumors, including neuroblastoma.
-
CLINICAL_TRIALS trial_result · 2016-02-04Clinical Trial Update: A Phase II Study of Intensity Modulated Radiation Therapy (IMRT) in High Risk Abdominal Neuroblastoma [Phase 2]
A Phase II study evaluating intensity-modulated radiation therapy (IMRT) in high-risk abdominal neuroblastoma was terminated, with results p…
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: Studies of Temozolomide in Combination With Topotecan in Refractory and Relapsed Paediatric Solid Tumours [Phase 2]
This Phase 2 trial update notes the completion of studies evaluating temozolomide in combination with topotecan for refractory and relapsed …
-
CLINICAL_TRIALS trial_result · 2016-01-21Clinical Trial Update: Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients [Phase 1]
Phase 1 safety study of a recombinant vaccinia virus (JX-594/Pexa-Vec) for refractory pediatric solid tumors. The trial has completed and en…
-
CLINICAL_TRIALS trial_result · 2016-01-07Clinical Trial Update: Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation [NA]
This clinical trial update reports completion of a study evaluating Traumeel S for prevention and treatment of mucositis in pediatric stem c…
-
CLINICAL_TRIALS trial_result · 2015-11-25Clinical Trial Update: Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors [Phase 2]
Arsenic trioxide was studied in a Phase 2 trial for children with advanced neuroblastoma and other childhood solid tumors; results have been…
-
CLINICAL_TRIALS trial_result · 2015-11-24Clinical Trial Update: Vorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent Neuroblastoma [Phase 1]
This clinical-trial update reports the completion of a Phase 1 study evaluating a combination of vorinostat and isotretinoin in patients wit…
-
CLINICAL_TRIALS trial_result · 2015-09-28Clinical Trial Update: Iodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Treating Patients With Relapsed or Refractory Neuroblastoma [Phase 1]
A completed Phase 1 study evaluating the combination of 3F8 (Iodine-131 labeled monoclonal antibody) and bevacizumab in relapsed or refracto…